🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to evaluate efficacy and safety of regorafe...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-14
Trial ID
NCT01774344
Treatments Being Tested
This study is a multicenter, prospective, randomized controlled Phase II cl...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital, 52 Fucheng Road
Start Date
2025-07-30
Trial ID
NCT06772233
Treatments Being Tested
Continuous dosing of BAY73-4506 in patients with advanced cancer...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT01117623
Treatments Being Tested
Multicenter double-blind placebo-controlled randomized Phase II study compa...
Status
Completed
Location
CHRU Besançon
Start Date
2019-05-15
Trial ID
NCT03793361
Treatments Being Tested
The focus of this study will be to investigate whether Regorafenib demonstr...
Status
Recruiting
Location
IRST Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
Start Date
2024-09-23
Trial ID
NCT06275919
Treatments Being Tested
This is a single arm, single-stage, phase II trial to evaluate the activity...
Status
Completed
Location
Istituto Clinico Humanitas
Start Date
2014-12
Trial ID
NCT02307500
Treatments Being Tested
This is a study to evaluate the efficacy (effectiveness) and the safety of ...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01289821
Treatments Being Tested
There are in total 3 cohorts. Cohort A: 16 patients will receive a daily do...
Status
Unknown
Location
UZ Brussels
Start Date
2022-10-03
Trial ID
NCT05370807
Treatments Being Tested
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM A...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-07-30
Trial ID
NCT03970447
The purpose of this study is to enable participants, currently receiving re...
Status
Completed
Location
Tampa General Medical Group
Start Date
2019-04-02
Trial ID
NCT03890731
Treatments Being Tested